(Linagliptin 2.5mg + Metformin Hydrochloride 850mg): A type 2 diabetes treatment for adults.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Adlinameg 2.5/850mg Tablet: Balancing Blood Sugar with Metformin and Linagliptin.
Avoid consumption of alcohol during treatment with Adlinameg 2.5/850mg Tablet due to the increased risk of undesired effects.
Adlinameg 2.5/850mg Tablet is not recommended for use during pregnancy unless necessary. If you are pregnant, consult your doctor before taking this medicine.
Adlinameg 2.5/850mg Tablet is not recommended for use during pregnancy unless necessary. If you are pregnant, consult your doctor before taking this medicine.
Drive only when physically stable and mentally alert. If you feel drowsy after taking these medications, avoid driving or operating machinery. Your safety and the safety of others are paramount.
Adlinameg 2.5/850mg Tablet is not recommended for use in patients with severely reduced kidney functions. Therefore, consult your doctor before taking it.
Adlinameg 2.5/850mg Tablet is not recommended for use in patients with severe liver problems. It should be used with caution in patients with gallstones. Therefore, consult your doctor before taking it.
Adlinameg 2.5/850mg Tablet is a combination of two active ingredients: Metformin and Linagliptin. Metformin improves the body's sensitivity to insulin, helping to regulate blood sugar levels, and reduces the liver's production of sugar. Linagliptin, on the other hand, enhances insulin release from the pancreas and boosts the activity of a hormone called Glucagon-like peptide-1, which aids in controlling blood sugar levels. This combination medication is used to manage and regulate blood sugar in individuals with type 2 diabetes.
Common side effects of Adlinameg 2.5/850mg Tablet may include nausea, diarrhea, stomach pain, and changes in taste like a metallic taste. Uncommon effects could involve inflamed nose or throat, cough, constipation, loss of appetite, vomiting, and skin itchiness. Rare side effects that warrant immediate medical attention include:
If you experience any of these rare side effects, stop taking the medication and consult your doctor immediately.
Adlinameg is prescribed to adult patients with type 2 diabetes mellitus to enhance glycemic control. It serves as an additional treatment alongside diet and exercise in cases where patients are not effectively managed with their maximum tolerated dose of metformin alone. It is also utilized in patients already receiving a combination of linagliptin and metformin.
Furthermore, Adlinameg is indicated as part of triple combination therapy. When used with sulphonylurea, it complements diet and exercise for adult patients whose metformin and sulphonylurea treatment does not suffice for proper glycemic control. Similarly, when combined with insulin, it helps improve glycemic control for adults whose current regimen of insulin and metformin is insufficient.
Linagliptin aids individuals with type 2 diabetes in controlling blood sugar levels. By inhibiting the enzyme DPP-4 (dipeptidyl peptidase-4), it prevents the degradation of incretin hormones like GLP-1 and GIP. This action prompts insulin release from pancreatic beta cells while decreasing glucagon production by pancreatic alpha cells. The result is increased active incretin hormone levels, which help regulate blood sugar.
Metformin Hydrochloride belongs to the biguanide class and acts as an antihyperglycemic medication for type 2 diabetes. It reduces both baseline and postprandial blood glucose levels. Unlike sulfonylureas, it doesn't cause hypoglycemia. Metformin works by decreasing hepatic glucose synthesis, absorption of glucose in the intestines, and enhancing insulin sensitivity, ultimately improving peripheral glucose uptake and utilization.
Linagliptin & Metformin tablet: Dosage varies based on effectiveness and tolerance. Max recommended dose is 2.5mg Linagliptin + 1000mg Metformin twice daily with meals. Start with 2.5mg Linagliptin + 500mg Metformin if not on Metformin. Adjust the dose if already on Metformin or Linagliptin. Components can be switched to this combo.
Linagliptin & Metformin extended-release tablet: Dosage varies based on effectiveness and tolerance. Max recommended dose is 5mg Linagliptin + 2000mg Metformin once daily with a meal. Start with 5mg Linagliptin + 1000mg Metformin if not on Metformin. Adjust the dose if already on Metformin or Linagliptin. Switch from immediate release to extended release with the same Linagliptin dose and similar Metformin dose.
When taking multiple medications or combining them with specific foods or beverages, there's a risk of drug interactions. Here are some important interactions and precautions to consider while using Adlinameg 2.5/850mg Tablet:
Interaction with Alcohol: Avoid alcohol consumption while taking this medication. If you experience symptoms like prolonged weakness, muscle pain, sleeplessness, or breathing difficulties after alcohol intake, inform your doctor immediately. Alcohol use can increase the risk of lactic acidosis, so it's best to limit or avoid its consumption.
Interaction with Other Medications:
Interaction with Medical Conditions:
Interaction with Food:
Being aware of these interactions and precautions can help you use Adlinameg 2.5/850mg Tablet safely and effectively. Always consult your doctor before making any changes to your medication regimen.
Avoid using this medicine if:
This medication should be used with caution during pregnancy and while breastfeeding. As there are no sufficient and well-controlled trials in pregnant women with this combination or its separate components, it should only be taken if clearly necessary during pregnancy. If given to a nursing woman, extreme caution should also be exercised. It's important to discuss the potential risks and benefits with your healthcare provider before taking this medication if you are pregnant or breastfeeding. Your doctor will help you make an informed decision based on your individual circumstances.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.